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Early temporary windows of heightened brain plasticity called critical periods develop-
mentally sculpt neural circuits and contribute to adult behavior. Regulatory mechanisms
of visual cortex development – the preeminent model of experience-dependent critical
period plasticity-actively limit adult plasticity and have proved fruitful therapeutic targets
to reopen plasticity and rewire faulty visual system connections later in life. Interestingly,
these molecular mechanisms have been implicated in the regulation of plasticity in other
functions beyond vision. Applying mechanistic understandings of critical period plasticity in
the visual cortex to fear circuitry may provide a conceptual framework for developing novel
therapeutic tools to mitigate aberrant fear responses in post traumatic stress disorder. In
this review, we turn to the model of experience-dependent visual plasticity to provide novel
insights for the mechanisms regulating plasticity in the fear system. Fear circuitry, particu-
larly fear memory erasure, also undergoes age-related changes in experience-dependent
plasticity. We consider the contributions of molecular brakes that halt visual critical period
plasticity to circuitry underlying fear memory erasure. A major molecular brake in the visual
cortex, perineuronal net formation, recently has been identified in the development of fear
systems that are resilient to fear memory erasure. The roles of other molecular brakes,
myelin-related Nogo receptor signaling and Lynx family proteins – endogenous inhibitors
for nicotinic acetylcholine receptor, are explored in the context of fear memory plasticity.
Such fear plasticity regulators, including epigenetic effects, provide promising targets for
therapeutic interventions.
Keywords: critical period, visual cortex plasticity, fear erasure, perineuronal nets, lynx1, HDAC inhibitors,
reconsolidation update
INTRODUCTION
As the brain develops, particular regions undergo different critical
periods of plasticity when their underlying circuits gain heighted
sensitivity to experience (1, 2). Experience during these early
temporal periods has a profound effect on the wiring of skills
and behaviors, such as language, music playing, visual processing,
and emotional processing. When the critical period for a region
closes, the adaptations in its circuitry become fixed, locking in
adjusted ways of processing and responding to stimuli and bring-
ing plasticity into a latent state. This mechanism is normally a
beneficial way to retain optimized behaviors without need for
maintenance or renewal. However, in individuals exposed to inap-
propriate stimuli, adaptive changes that were helpful during this
window of developmental plasticity may not be beneficial in the
future and can lead to dysfunctional behavior. Understanding the
mechanisms that open and close critical period development can
inform interventional strategies that attempt to modify these path-
ways later in life. In this review, we turn to the visual cortex as
a well-developed model of experience-dependent critical period
plasticity to provide novel insights for the mechanisms regulating
plasticity in the fear system.
CRITICAL PERIODS ACROSS BRAIN FUNCTIONS
CRITICAL PERIOD FOR VISUAL CORTEX PLASTICITY
The visual system offers valuable insight through the study of criti-
cal period mechanisms. In humans and animals, visually depriving
one eye by obstructing it early in life yields loss in visual acu-
ity (amblyopia) by stimulating an anatomical remodeling within
primary visual cortex (3). Importantly, such an effect of visual
deprivation has not been seen in the adult, strongly suggesting the
presence of a developmental critical period for visual experience-
dependent plasticity in visual cortex. Due to a lack of sufficient
brain plasticity in adulthood, untreated monocular deprivation
during childhood results in life-long amblyopia, a condition affect-
ing 2–5% of the human population (4). Indeed, recovery from
deprivation amblyopia in adulthood is limited across species,
from higher mammals (3), to rodents (5, 6), and requires ther-
apeutic intervention. Over the last 10 years, the murine visual
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system, has emerged as a valuable model system for creating
such intervention, having a well-defined, 2 week critical period
that peaks 1 month after birth (Figure 1A). The predictability
and duration of this temporal window is particularly useful for
dissecting the molecular mechanisms of visual cortex plasticity
through genetic manipulation and environmental intervention
(7). Critical period mechanisms identified in rodent visual cortex
have not only catalyzed multiple pharmacological and behavioral
interventions that aid functional recovery in adults (8), but have
also guided research uncovering molecular mechanisms of critical
period plasticity in other brain regions, especially the auditory and
fear systems (9–11).
CRITICAL PERIOD FOR FEAR MEMORY ERASURE
Evidence from both animal and human studies suggest that
the pathways underlying fear systems also undergo age-related
changes in experience-dependent plasticity. Such age-related
changes have been observed in both fear memory acquisition
and extinction. Fear acquisition, measured through the ability
to develop conditioned context-shock fear responses, does not
emerge until 13–14 days (12). However, the mechanism govern-
ing the age-dependent change is little explored. Developmental
differences in fear extinction, characterized by the ability to re-
encode a previously encoded fear response, are observed in human
studies and translate to rodent models, providing an effective ani-
mal model for exploring fear circuitry plasticity mechanisms. Fear
extinction may be temporary, or it can lead to permanent fear
memory erasure. The outcome of fear extinction is age-dependent.
Fear extinction during a critical period in preadolescent mice (P13-
17), leads to permanent fear erasure (13, 14). On the other hand,
mice extinguished 24 days after birth or later exhibit a returned fear
response (15) (Figure 1B). The juvenile form of fear extinction is
also marked by an accelerated rate of change compared to that of
adult mice (16), but the mechanistic relationship between the per-
sistence and rate of fear extinction is unknown. Current evidence
also suggests that erasure is specific to early temporal windows
following a traumatic event (1–3 days later), as rodents under-
going later extinction training exhibit long-term hyper-vigilance
rather than complete erasure (17). Understanding the mechanisms
underlying these age-related changes in fear system plasticity may
contribute to the better understanding of fear disorders, such as
post traumatic stress disorder (PTSD), that are characterized by
the re-experiencing of the traumatic events, hyper-vigilance, and
persistent dysfunctional wiring of fear circuitry (18, 19).
PARALLELS BETWEEN VISUAL AND FEAR SYSTEM PLASTICITY
To what extent are visual and fear system critical period mech-
anisms parallel? Both the visual and fear systems maintain a
developmentally limited ability to rewire connections that are
no longer functionally appropriate. In the visual system, criti-
cal period (but not adulthood) monocular deprivation triggers
a functional re-adaptation via visual cortex restructuring that
reduces the input from the visually deprived eye. Early develop-
ment fear extinction modifies behavior by erasing fear memories
that are no longer appropriate, and differs from adult extinc-
tion that is temporary and slower. Thus, to discuss the role of
molecular regulators in critical periods of plasticity, we consider
them within their functional contexts and in functional parallels
between systems.
To interrogate the extent to which the regulatory mechanisms
of critical period plasticity in the visual system apply to the fear
system, we conceptually consider “permanent fear erasure” anal-
ogously to “amblyopia,” both of which are only induced during
critical period. Accordingly, we also consider “fear extinction pro-
cedure” in fear system and “monocular deprivation” in the visual
system as the inducers of plasticity in each system. Because the
juvenile form of fear extinction is also marked by accelerated
changes in response compared to that of adult mice (16), we
consider both the rate and persistence of fear memory extinc-
tion as the measures of fear plasticity. Although the following
discussion focuses on this parallel nature of plasticity between
visual and fear system development, it should be noted that addi-
tional mechanisms likely contribute to the age-related changes
described, including fear memory erasure due to increased rates
of neurogenesis during development (20).
MOLECULAR BRAKES: COMMONMECHANISMS FOR
CRITICAL PERIOD CLOSURE?
Recent studies using rodent visual cortex have identified mul-
tiple structural and functional molecular “brakes” that actively
limit plasticity and close the critical period in the adult brain
(8, 21). Structural brakes include PNNs (22), myelin-related
inhibitory signaling mediated by Nogo receptor (23), and paired
immunoglobulin-like receptor B expression (PirB) (24). Func-
tional brakes, such as the nicotinic receptor binding protein Lynx1
act upon excitatory-inhibitory balance within local circuits (25).
Importantly, lifting these brakes can induce critical period plastic-
ity in adulthood and re-introduce ocular dominance remodeling
following monocular deprivation. Here, we consider the potential
roles of these major brakes explored in the visual system within
fear circuitry.
PERINEURONAL NETS
Perineuronal nets are extracellular macromolecular aggregates
associated with several subclasses of chondroitin sulfate pro-
teoglycans (CSPGs) that surround neuronal cell bodies and
proximal dendrites (26). In the visual system, PNNs inhibit
experience-dependent plasticity observed during the critical
period (Figure 1A). Further organization of CSPGs into PNNs
coincides with the end of the critical period. Interestingly, PNN
degradation with chondroitinase-ABC, an enzyme that degrades a
key linkage glycoprotein and attacks CSPG side chains that allow
the aggregates to form, restores experience-dependent plasticity in
adult rats (22). Mice lacking a cartilage link protein that attenu-
ates PNNs, Crtl1, consistently retain juvenile levels of plasticity in
the adult visual cortex (27). Further, chondroitinase-ABC treat-
ment coupled with reverse lid-suturing in adult rats – opening the
sutured lid of the visually deprived eye while suturing the lid of
the other, visually active eye – causes a complete recovery of ocular
dominance to the originally deprived eye. This shift is accompa-
nied by an increase in visual acuity and dendritic spine density
(28). Although the underlying mechanisms by which PNNs halt
plasticity remain elusive, a possible explanation for the protec-
tive action of PNNs is that they change the dynamics of local
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GABAergic inhibition. PNNs form primarily around parvalbu-
min (PV)-positive GABAergic interneurons, which are involved
in the onset of critical period in the visual cortex. Recent studies
further showed that the expression of PNNs is regulated by the cel-
lular transfer of the homeodomain transcription factor Otx2 from
the retina and Choroid-plexus to the visual cortex. This home-
oprotein signals PV maturation in GABAergic interneurons and
contributes to both the opening and closure of the critical period
(29–32) (Figure 1A).
In the fear system, the PNNs in the amygdala recently have been
shown to play a central role in modifying the plasticity of fear
memories and may contribute to protection against fear mem-
ory lability during acquisition. The number of CSPG containing
PNNs increases in the murine amygdala between days 16 and 23 –
the time coinciding with preadolescence and the developmentally
related functional switch from fear erasure to less effective fear
extinction (10) (Figure 1B). A recent study removing amygdala
PNNs with chondroitinase-ABC supports the role of PNNs as a
FIGURE 1 | Critical Period for experience-dependent plasticity in visual
and fear system. (A) Critical period of visual cortex plasticity: visual cortex
development is the preeminent model for the study of critical period plasticity
and its regulators. Visually depriving one eye by obstructing it early in life
yields a life-long loss of visual acuity (amblyopia). Studies of mouse visual
cortex development, which has a well-defined 2 weeks critical period that
peaks at 1 month after birth, have identified several endogenous “molecular
brakes” (colored in red) that close the critical period. These include
perineuronal nets (PNNs), myelin-related Nogo receptor (NgR) and PirB, and a
nicotinic brake Lynx1. (B) Critical period of fear erasure: a critical period for the
fear system near adolescence is emerging through current research. In
rodents, extinction can permanently erase fear memory during a
preadolescent critical period around 17 days after birth, however, extinction at
24 days or later fails to bar fear memories from re-emerging. Increased PNNs
in the amygdala and maturation of input from medial prefrontal cortex (mPFC)
to amygdala contribute to the closure of this critical period. Nogo receptor
(NgR: colored in light red) also limits fear extinction, but its contribution on
fear erasure is not tested. (C) Interventions for enhancing visual cortex
plasticity in the adult: counteracting molecular brakes through
pharmacological (ChABC, SSRI, HDACI, AChEI: colored in green) and
behavioral (environmental enrichment, dark exposure) approaches is a
promising therapeutic strategic for recovery from amblyopia. (D) Interventions
for fear erasure in the adult: juvenile-like plasticity can be reintroduced in
adulthood through pharmacological treatment (ChABC, SSRI treatment) or
reconsolidation update. HDACI administration (colored in light green)
enhances extinction, but its effect on fear erasure has not been examined yet.
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plasticity brake that actively protects fear memories from erasure
(10). When adult mice are injected with chondroitinase-ABC prior
to fear conditioning and followed by extinction training 2–3 days
later, fear extinction proceeds at a rate similar to that observed in
juvenile mice, suggesting a greater response to extinction training
(Figure 1B). Interestingly, chondroitinase-ABC was only effec-
tive when injected before fear conditioning; injection prior to
extinction but after fear training was ineffective. Thus, the CPSG
aggregation is likely involved in the initial fear memory encod-
ing, and plays a role in maintaining the extinction-resistance of
the fear memory rather than regulating the processes which occur
during extinction. When the fear response was tested several weeks
after the extinction training, the mice did not show a fear response
to either the conditioned stimulus or the context of fear train-
ing, while control mice showed substantial renewal of the fear
response (10). Thus formation of PNNs in fear systems may alter
the function of local inhibitory circuits to promote the formation
of extinction-resistant memory trace during fear conditioning,
and degradation of these nets may allow for more inhibitory con-
nectivity to protect against fear memory lability. In a post-mortem
case control study, schizophrenic patients exhibited reduced num-
bers of PNNs in the lateral amygdala nuclei and entorhinal cortex
(33). Further, oxidative stress, frequently observed in peripheral
tissues and brains of schizophrenia patients, has been shown to
delay the formation of PNNs (34, 35). The disruption of PNNs
may play a central role in disease pathogenesis. It is currently dif-
ficult to discern whether the PNN is exerting an effect on fear
acquisition or extinction because the downstream effectors of
PNN disruption have not yet been identified. To better understand
the role of the PNN in fear systems, further studies are needed
to examine how PNNs are controlled and how they exert their
effects.
MYELIN-RELATED NOGO RECEPTOR SIGNALING
In the visual cortex, experience-dependent plasticity is limited
by myelin-related Nogo receptor signaling (23). The end of the
visual critical period coincides with the maturation of intracor-
tical myelin, which contains myelin-related inhibitory proteins
such as NogoA, MAG, and OMgp, all of which bind to the neu-
ronal Nogo receptor (36) (Figure 1A). Nogo receptor knock-out
mice maintain normal levels of plasticity during the critical period,
however the plasticity is maintained beyond critical period for up
to 120 days postnatally (23). Additionally, PirB, a paired receptor
with high affinity for Nogo, is also found to restrict ocular dom-
inance plasticity in the visual cortex (24) (Figure 1A). The Nogo
receptor was recently shown to be also involved in determining the
rate of synaptic turnover in the adult cerebral cortex, as knock-out
mice have increased levels of synaptic turnover (37). These myelin-
related brakes may also regulate structural plasticity at the level of
dendritic spine.
In a recent study, Nogo receptor knock-out mice were reported
to show more pronounced fear extinction compared to wild type
mice (37) (Figure 1B). At the dendritic spine level, fear extinc-
tion 3–4 days after fear conditioning involves spine growth on the
same dendritic branches within 2µm from the spines that were
eliminated during conditioning in the cortex (38). Removal of
a Nogo receptor brake may return high synaptic turnover which
can result in stronger fear extinction learning (37). Whether or not
Nogo receptor signaling contributes to fear erasure mechanisms in
a fashion similar to PNNs is question that remains to be examined.
LYNX FAMILY
While structural brakes can limit plasticity by altering local con-
nectivity, functional brakes can also halt plasticity by altering the
neurotransmission between connections that have been formed to
facilitate plasticity. In the visual cortex, a newly discovered class
of proteins, the Lynx family, has been recently identified as a class
of functional brakes (25). Lynx1, an endogenous prototoxin sim-
ilar to α-bungarotoxin in snake venom, acts by binding to the
nicotinic acetylcholine receptor (nAChR) and limiting its acti-
vation (39). Increases in Lynx1 expression coincide with closure
of the critical period in the adult mouse visual cortex. Further,
removal of this molecular brake during adulthood re-induces a
plastic state by acutely resetting local excitatory-inhibitory circuit
balance. Lynx1 expression in adults suppresses functional plastic-
ity into a latent state, as removal of this brake allows the critical
period remains open until nAChR signaling is actively blocked (25)
(Figure 1A). The adult Lynx1 knock-out mice that received ambly-
opic long-term visual deprivation during critical period showed
spontaneously recovery of visual acuity to normal levels simply
by reopening the closed eye (25). While a permissive role for
ACh has long been appreciated during the critical period (40),
it has remained a mystery why visual cortex plasticity is severely
restricted in adulthood even in the presence of massive cholinergic
innervation from the basal forebrain. Lynx1 provides a molecular
basis for maintaining stability in the presence of ACh.
The Lynx family may also have developmental roles in fear
system. Lynx1 and closed related Lynx2 are both expressed in
the amygdala and change its expression levels across develop-
ment in both rodent and human (41). Both Lynx1 and Lynx2
knock-out mice express an amplified response to cue fear con-
ditioning, but demonstrate normal contextual fear conditioning
in adulthood (42, 43). As the juvenile cue response is normally
stronger than that of the adult (44), Lynx family proteins may
dampen cue-conditioned fear learning from adolescence to adult-
hood. Considering its age-related changes in expression, the Lynx
family may also have a role on extinction and critical period of fear
memory erasure. Indeed, nicotine administration during extinc-
tion training over the course of 6 days after fear conditioning is
reported to enhance extinction (45), however, the direct role of
Lynx family proteins in fear memory erasure remain to be tested.
THERAPEUTIC STRATEGIES BASED ON CRITICAL PERIOD
MECHANISMS
The ability to remove brakes on critical periods provides the
opportunity to reopen windows of plasticity in order to remodel,
or re-develop, the adult brain by re-introducing juvenile-like plas-
ticity. Small molecules targeting these brakes carry potential clini-
cal relevance for both neurological and psychiatric disease, includ-
ing PTSD. It is well-established that administering d-cycloserine
(DCS), a partial NMDA agonist, facilitates extinction, and pre-
vents the recovery of fear memories in rats, mice, and humans
both before and after extinction training (46–49). Here we discuss
the possibility of additionally using three well-established drug
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classes administered in humans – selective serotonergic reuptake
inhibitors (SSRIs), acetylcholinesterase inhibitors (AChEIs), and
histone deacetylase (HDAC) inhibitors – to target both struc-
tural and functional plasticity brakes based on data from both
animal and human studies (Figure 1C). Finally, we also consider
behavioral interventions such as reconsolidation update, which
may mimic or trigger similar effects.
SEROTONERGIC REUPTAKE INHIBITORS
In animal studies, chronic SSRI treatment reintroduces juvenile-
like plasticity to the adult visual cortex. Administration of fluoxe-
tine, the first-line antidepressant SSRI, has been demonstrated to
restore critical period plasticity in the adult rat brain (50). Chronic
fluoxetine treatment in adult rats not only induced visual cortex
plasticity after monocular deprivation, but also improved visual
acuity in amblyopic animals (Figure 1C). Specifically, rats were
treated with fluoxetine for 4 weeks underwent monocular depri-
vation on day 21 of treatment. Increased BDNF levels in the visual
cortex were accompanied by reduced GABAergic inhibition, likely
restoring excitatory-inhibitory balance by reopening visual critical
period plasticity.
Plasticity reactivation by chronic SSRI treatment has recently
been examined in the fear system. Strikingly, fear erasure is facil-
itated in adult mice by SSRI treatment and resembles fear erasure
in non-treated juvenile mice (Figure 1D) (51). Chronic fluoxetine
treatment for 3 weeks prior to and throughout the duration of fear
conditioning does not influence the encoding of a conditioned
fear response, but rather causes faster extinction and permanent
erasure compared to mice that undergo extinction training with-
out prior SSRI treatment. This effect is mediated through BDNF
pathways: BDNF expression was exaggerated in the basolateral
amygdala by SSRI treatment, and the effect of SSRI on fear erasure
was absent in mice heterozygous for BDNF allele. Interestingly,
SSRI treatment starting after the fear acquisition was sufficient to
induce faster extinction and permanent erasure,a salient difference
compared to fear erasure induced by PNN disruption, which was
only effective when treated before and not after fear conditioning.
Fluoxetine treated mice had similar number of PNN-positive neu-
rons compared to control but had a reduced percentage of PNN
expressing parvalbumin interneurons in the basolateral amygdala.
Together, these data suggest that fluoxetine treatment selectively
shifts parvalbumin interneurons toward an immature state, induc-
ing critical period-like plasticity in local inhibitory neurons in
the basolateral amygdala. The effects of chronic fluoxetine treat-
ment (4–5 weeks) were also seen in CA1 of the hippocampus,
where SSRIs have been shown to return mature granule cells to
an electrophysiologically immature state, with reduced synaptic
facilitation in the mossy fibers (52). Loss of hippocampal synaptic
proteins has been associated with a PTSD-like syndrome in mice,
and is counteracted with SSRI treatment for 4 weeks of chronic
fluoxetine treatment prior to fear conditioning (53).
ACETYLCHOLINESTERASE INHIBITORS
Another class of pharmaceutical agents shown to induce recov-
ery of visual function in the adulthood is the acetylcholinesterase
inhibitor (AchEI). In the visual system, AchEI injection can restore
vision in adult wild type mice with amblyopia, a disorder in
which the eye, though structurally normal, has impaired vision
due to poor functional connectivity to the visual cortex (25)
(Figure 1C). By increasing cholinergic tone, AChEI may coun-
teract the nicotinic functional brake Lynx1 on critical period
plasticity.
AchEI treatment has not been directly examined in the context
of fear extinction and memory liability, but nicotine dosing imme-
diately before training has been reported to enhance extinction
training (45). As AChEI can rapidly activate BDNF receptor TrkB
in hippocampus, AChEI may have similar effect on fear memory
liability to SSRI (54). However, further studies are clearly needed to
better elucidate the effects that AchEI have on fear system plasticity.
HDAC INHIBITORS
In the visual system, experience-dependent modifications of his-
tone acetylation are developmentally down-regulated, implicating
epigenetic mechanisms in the regulation of critical period plas-
ticity (55). Administration of the HDAC inhibitor trichostatin A
in adult mice reactivates visual cortex plasticity (55) and chronic
administration of two separate HDAC inhibitors, valproic acid and
sodium butyrate, to amblyopic adult mice undergoing long-term
monocular deprivation induces recovery of visual acuity follow-
ing reverse lid-suturing (56) (Figure 1C). Although the effect of
HDAC inhibitors is intriguing, the changes in genetic expression
profiles that HDAC inhibitors produce, and subsequent down-
stream effects of visual cortical plasticity, are still unknown. One
possibility is that HDAC inhibitors are regulating gene expres-
sion of molecular brakes, such as myelin-related molecules, as
histone modifications are involved in oligodendrocyte precursor
cell differentiation during development. Some potential gene tar-
gets include transcription factors required for myelination, such
as SOX10 and Krox-20. Administration of an HDAC inhibitor
during myelination onset, which coincides with the fall of the
visual cortex critical period, prevents oligodendrocyte precursor
cell maturation (57–59). However, further analyses are required
to unravel the effectors of the epigenetic treatment on visual plas-
ticity and to confirm that effects are specific enough to plasticity
brakes to be of clinical benefit.
In the fear system, systemic, as well as direct, application of
HDAC inhibitors into the hippocampus or medial prefrontal
cortex (mPFC) prior to fear conditioning and prior to extinc-
tion enhances extinction learning (60–64) (Figure 1D). Oral
administration of an HDAC inhibitor enhances extinction learn-
ing in response to weak extinction protocols that are ineffec-
tive when administered on their own, and direct application of
HDAC inhibitors to the hippocampus and mPFC increases c-
fos expression. Future studies are necessary to determine whether
HDAC inhibitors also promote permanent erasure of fear memory.
Research comparing adult histone acetylation activity to juvenile
activity will also inform whether acetylation has developmental
specificity and mechanistic contributions to the critical period for
fear lability.
BEHAVIORAL INTERVENTIONS
Visual system
Environmental enrichment (65) and dark exposure (66) have been
reported as effective behavioral interventions for recovery from
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amblyopia in adult rats (Figure 1C). These interventions may reset
excitatory – inhibitory balance, thus re-introducing juvenile-like
plasticity in the adult brain (8). The effects of behavioral interven-
tions on recovery from adult amblyopia have also been examined
in humans. Perceptual learning, involving extensive practice on a
challenging discrimination between simple visual stimuli (67–69),
and action videogames, which requires the allocation of spatial
attention, detection, and localization of low contrast, fast mov-
ing targets, emerge as tools for visual acuity improvements in
adult amblyopia (70, 71). These interventions may induce plas-
ticity by either lifting molecular brakes through invasive inter-
ventions or by exploiting endogenous permissive factors such as
neuromodulators (21).
Fear system
A newly proposed behavioral intervention for treating PTSD,
“reconsolidation update,” involves targeting traumatic memories
as an individual reconsolidates it because the memory is rendered
labile after it has been recalled (Figure 1D). Extinguishing a fear
response during the window of reconsolidation prevents the rein-
statement of a fear response to a stimulus at a later time point
in both humans and in rodents (72–74). It is notable that the
mechanisms of this process are localized to the amygdala and
exclude the mPFC (75, 76). The mPFC is thought to be involved
in reactivation of emotional states associated with past experi-
ences, which may account for the lower rate of PTSD among war
veterans with selective mPFC damage (77). The mPFC is also unin-
volved in juvenile fear systems (Figure 1B) (78). Extinction during
reconsolidation involves the amygdala in both juvenile mice and
humans, and the mPFC is uninvolved in adolescent rat extinc-
tion (15, 79). During reconsolidation, events in the amygdala may
open a temporal window of experience-dependent plasticity that
allows a fear memory to be degraded by new experiences. How-
ever, it should be also noted that facilitation of extinction may also
happen in addition to reconsolidation update (80). The molecu-
lar mechanisms of fear erasure by reconsolidation update are only
now beginning to be explored. Recent work suggests that phos-
phorylation of the AMPA receptor subunit GluA1 regulates this
process (72). There is also increasing evidence that reconsolida-
tion is accompanied by epigenetic changes, pointing to a potential
effect of epigenetic regulation on the cellular alterations under-
lying experience-dependent plasticity (81–85). Whether or not
reconsolidation update limits the expression of molecular brakes
remains open to future investigation. Combining reconsolidation
update and pharmacological interventions may be a fruitful future
direction.
CONCLUSION
In this review, we considered the potential contributions of “mol-
ecular brakes” identified in visual system development, the major
model of critical period plasticity, to the development of fear
system connections. Striking similarities between the molecu-
lar mechanisms underlying the development of these two brain
regions, as well as therapeutic approaches to their dysfunction,
indicate that new mechanisms identified in the visual critical
period can provide both novel insights and a conceptual frame-
work for exploring novel therapeutic approaches to aberrant
fear responses in PTSD patients. Future studies examining the
contributions of molecular brakes, such as myelin-related nogo
receptor signaling and the Lynx family, as well as their epigenetic
regulators in the context of the fear system development, may
shed light on new targets for therapeutic intervention. The inter-
actions between multiple brakes have yet to be connected – not
only those mentioned in this review, but also well-established age-
related mechanisms, such as hippocampal neurogenesis. Future
research manipulating critical period mechanisms for clinical use
will require further elucidation of systems in which these molec-
ular brakes are involved. The mechanism of re-closure after the
therapeutic reopening the critical period is another important
area of investigation. Finally, better comprehension of the scope
of these regulators to realize both their therapeutic potential as
well as the undesired consequences of increased brain plasticity is
needed.
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